1) leukotriene antagonist
白三烯受体阻滞剂
1.
Ibudilast,a new leukotriene antagonist and phosphodiesterase inhibitor;
白三烯受体阻滞剂和磷酸二酯酶抑制剂异丁司特
2) The-blocker
受体阻滞剂
1.
The-blocker acts different according to its different chemical structure,its application is more wider,especially the application in cardiovascular diseases.
受体阻滞剂根据其化学结构不同,其应用也不同,特别是在心血管病中的应用,越来越广泛。
3) a-adrenoreceptor blocker
a受体阻滞剂
1.
Objiective:To observe the impact of a-adrenoreceptor blocker of rabbit renal pelvis pressure of obstruction.
目的:观察a受体阻滞剂对梗阻后兔肾盂压力的影响。
5) Leukotriene receptor antagonists
白三烯受体拮抗剂
1.
Application of leukotriene receptor antagonists in childhood disease
白三烯受体拮抗剂在儿科疾病中的应用现状
2.
RESULTS & CONCLUSION:Leukotriene receptor antagonists have become the most effective mediator antagonists in clinic treatment of asthma and which are currently widely used in the clinic.
目的:评价白三烯受体拮抗剂的临床应用概况。
3.
OBJECTIVE: To evaluate the efficacy and safety of leukotriene receptor antagonists (LTRAs) for exercise-induced asthma (EIA).
已有两篇Cochrane系统评价证实白三烯受体拮抗剂单独或联合吸入糖皮质激素治疗可使哮喘患者中度获益。
6) Leukotriene receptor antagonist
白三烯受体拮抗剂
1.
Protective effect of ONO-1078,a leukotriene receptor antagonist,on focal cerebral ischemia induced by endothelin-1 in rats;
白三烯受体拮抗剂ONO-1078对内皮素-1诱导的大鼠局灶性脑缺血的保护作用
2.
Effect of leukotriene receptor antagonist on cough variant asthma
白三烯受体拮抗剂对咳嗽变异性哮喘的作用
3.
Objective: To investigate the influence of the leukotriene receptor antagonist (montelukast) on airway remodeling and the expression of cyclin D1 in a murine model of asthma, and to explore the role of montelukast in dealing with asthma.
目的:研究应用白三烯受体拮抗剂(孟鲁司特钠)对哮喘小鼠肺组织中细胞周期蛋白D1(CyclinD1)的表达影响及对支气管哮喘气道重塑的作用,探讨白三烯受体拮抗剂在哮喘治疗中的作用。
补充资料：受体阻滞剂
受体阻滞剂
receptor blocking agen?ts
能与受体结合，但并不激动受体，而同时又能阻止该受体激动剂与结合的药物。例如阿托品可与M胆碱受体结合，但不激动M受体，同时又能阻止M受体激动剂乙酰胆碱与M受体结合，从而表现抗乙酰胆碱的药理作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条